The protective effect of Azadirachta indica (neem) against metabolic syndrome: A review

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 300

This Paper With 13 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-24-3_003

تاریخ نمایه سازی: 6 اردیبهشت 1400

Abstract:

Metabolic syndrome is a condition associated with obesity, diabetes, dyslipidemia, and high blood pressure. Recently, the use of phytochemicals is suggested in the control and treatment of metabolic syndrome. The Azadirachta indica (neem) is an evergreen tree belonging to the family of Meliaceae. Multiple studies have been confirmed the anti-diabetic and anti-hypertension, anti-hyperlipidemia, and anti-obesity effects of neem. In this review, we reported the protective effects of neem against the complications of metabolic syndrome with a special focus on mechanisms that are involved. It has been shown that neem can control hyperglycemia and hypertension through over-expression of transcription factor nuclear factor erythroid ۲–related factor ۲ (Nrf۲) and anti-oxidant effects. Neem also reduced the glucose uptake through up-regulation of glucose transporter ۴ (GLUT۴) and inhibition of key intestinal enzymes such as glucosidases. Moreover, neem showed anti-hypertensive effects possibility via the block of calcium channels, up-regulation of endothelial nitric oxide synthase (eNOS), and extracellular signal-regulated kinases ۱/۲ (ERK۱/۲) signaling pathway. Anti-oxidant effects play an important role in protective mechanisms of neem against metabolic syndrome and its complications.

Authors

Fatemeh Yarmohammadi

Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

Soghra Mehri

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Nahid Najafi

Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

Sanaz Salar amoli

Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Hosseinzadeh

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Hu G, Lindstrom J, Jousilahti P, Peltonen M, Sjoberg ...
  • 2. Lee W-Y, Jung C-H, Park J-S, Rhee E-J, Kim ...
  • 3. Toms TE, Panoulas VF, John H, Douglas KM, Kitas ...
  • 4. Hamilton MT, Hamilton DG, Zderic TW. Role of low ...
  • 5. Mahdian D, Abbaszadeh-Goudarzi K, Raoofi A, Dadashizadeh G, Abroudi ...
  • 6. Saeed A, Feofanova EV, Yu B, Sun W, Virani ...
  • 7. Galavi A, Hosseinzadeh H, Razavi BM. The effects of ...
  • 8. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria ...
  • 9. Floreani A, Cazzagon N, Franceschet I, Canesso F, Salmaso ...
  • 10.    Lim S, Kakoly N, Tan J, Fitzgerald G, Bahri ...
  • 11.    Czech MP. Insulin action and resistance in obesity and ...
  • 12.    Chen L, Chen R, Wang H, Liang F. Mechanisms ...
  • 13.    Watanabe M, Yokotsuka M, Yamaoka K, Adachi M, Nemoto ...
  • 14.    Sanati S, Razavi BM, Hosseinzadeh H. A review of ...
  • 15.    Dehghani S, Mehri S, Hosseinzadeh H. The effects of ...
  • 16.    Razavi BM, Lookian F, Hosseinzadeh H. Protective effects of ...
  • 17.    Gupta SC, Prasad S, Tyagi AK, Kunnumakkara AB, Aggarwal ...
  • 18.    Selvaraj B, Periyasamy S. Indian medicinal plants for diabetes: ...
  • 19.    Patel SM, Venkata KCN, Bhattacharyya P, Sethi G, Bishayee ...
  • 20.    Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological ...
  • 21.    Nwobodo EI. Evaluation of antilipid peroxidation and hypolipidemic potentials ...
  • 22.    Igwenyi I, Eze A, Aja P, Elom S, Uraku ...
  • 23.    Moga MA, Bălan A, Anastasiu CV, Dimienescu OG, Neculoiu ...
  • 24.    Singaravelu S, Sankarapillai J, Chandrakumari AS, Sinha P. Effect ...
  • 25.    Shakib Z, Shahraki N, Razavi BM, Hosseinzadeh H. Aloe ...
  • 26.    Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic ...
  • 27.    Bouallegue A, Bou Daou G, Srivastava AK. Endothelin-1-induced signaling ...
  • 28.    Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role ...
  • 29.    Howden R. Nrf2 and cardiovascular defense. Oxid Med Cell ...
  • 30.    Shah AJ, Gilani A-H, Hanif HM. Neem (Azadirachta indica) ...
  • 31.    Omóbòwálé TO, Oyagbemi AA, Alaba BA, Ola-Davies OE, Adejumobi ...
  • 32.    Omóbòwálé TO, Oyagbemi AA, Ogunpolu BS, Ola-Davies OE, Olukunle ...
  • 33.    Obiefuna I, Young R. Concurrent administration of aqueous Azadirachta ...
  • 34.    Kochhar A, Sharma N, Sachdeva R. Effect of supplementation ...
  • 35.    Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of ...
  • 36.    Hassani FV, Shirani K, Hosseinzadeh H. Rosemary (Rosmarinus officinalis) ...
  • 37.    Yoshino G, Hirano T, Kazumi T. Dyslipidemia in diabetes ...
  • 38.    Pirinccioglu AG, Gökalp D, Pirinccioglu M, Kizil G, Kizil ...
  • 39.    El-Demerdash FM, Nasr HM. Antioxidant effect of selenium on ...
  • 40.    Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats ...
  • 41.    Araujo FB, Barbosa DS, Hsin CY, Maranhão RC, Abdalla ...
  • 42.    Davignon J, Cohn JS. Triglycerides: a risk factor for ...
  • 43.    Soni H, Patel S, Patel G, Paranjape A. Evaluation ...
  • 44.    Bisht S, Sisodia S. Anti-hyperglycemic and antidyslipidemic potential of ...
  • 45.    Hussain HEMA. Reversal of diabetic retinopathy in streptozotocin induced ...
  • 46.    Gutierrez RMP, Gómez YGY, Guzman MD. Attenuation of nonenzymatic ...
  • 47.    Satyanarayana K, Sravanthi K, Shaker IA, Ponnulakshmi R. Molecular ...
  • 48.    Gautam MK, Gangwar M, Singh SK, Goel RK. Effects ...
  • 49.    Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa ...
  • 50.    Perez-Gutierrez RM, Damian-Guzman M. Meliacinolin: a potent α-glucosidase and ...
  • 51.    Bangar OP, Jarald EE, Asghar S, Ahmad S. Antidiabetic ...
  • 52.    Dholi SK, Raparla R, Mankala SK, Nagappan K. In ...
  • 53.    Mgbeje BAI, Essien NA, Iwara IA, Egbung GE, Igile ...
  • 54.    Peer PA, Trivedi PC, Nigade PB, Ghaisas MM, Deshpande ...
  • 55.    Zuraini A, Vadiveloo T, Hidayat MT, Arifah A, Sulaiman ...
  • 56.    Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: ...
  • 57.    Boden-Albala B, Sacco RL. Lifestyle factors and stroke risk: ...
  • 58.    Malnick SD, Knobler H. The medical complications of obesity. ...
  • 59.    Mukherjee A, Sengupta S. Indian medicinal plants known to ...
  • 60.    Jayakumar K, Srinivasan M, Ramesh N, Sachan A, Umesh ...
  • 61.    Bogardus C, Lillioja S, Howard B, Reaven G, Mott ...
  • 62.    Dixit S, Maiya A. Diabetic peripheral neuropathy and its ...
  • 63.    Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers ...
  • 64.    Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: ...
  • 65.    Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage ...
  • 66.    Hörle S, Grüner F, Kroll P. Epidemiology of diabetes-induced ...
  • 67.    Coffey L, Gallagher P, Horgan O, Desmond D, MacLachlan ...
  • 68.    Cade WT. Diabetes-related microvascular and macrovascular diseases in the ...
  • 69.    Rains JL, Jain SK. Oxidative stress, insulin signaling, and ...
  • 70.    Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed ...
  • 71.    Pi J, Zhang Q, Fu J, Woods CG, Hou ...
  • 72.    Tanaka Y, Tran POT, Harmon J, Robertson RP. A ...
  • 73.    Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition ...
  • 74.    Tundis R, Loizzo M, Menichini F. Natural products as ...
  • 75.    St Augustines T. Effects of Vernonia amygdalina on biochemical ...
  • 76.    Razavi B, Hosseinzadeh H. A review of the effects ...
  • 77.    Akaberi M, Hosseinzadeh H. Grapes (Vitis vinifera) as a ...
  • 78.    Hosseini A, Hosseinzadeh H. A review on the effects ...
  • 79.    Joseph B, Jini D. Insight into the hypoglycaemic effect ...
  • 80.    Yaseen G, Ahmad M, Zafar M, Sultana S, Kayani ...
  • 81.    Dineshkumar B, Analava M, Manjunatha M. Antidiabetic and hypolipidaemic ...
  • 82.    Riyanti S, Suganda AG, Sukandar EY. Dipeptidyl peptidase-IV inhibitory ...
  • 83.    Ezuruike U, Prieto JM. Assessment of potential herb-drug interactions ...
  • 84.    Rameshrad M, Razavi BM, Ferns GA, Hosseinzadeh H. Pharmacology ...
  • 85.    Rameshrad M, Razavi BM, Lalau J-D, De Broe ME, ...
  • 86.    Green BD, Flatt PR, Bailey CJ. Dipeptidyl peptidase IV ...
  • 87.    Hsia SH, Bazargan M, Davidson MB. Effect of Pancreas ...
  • 88.    Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia ...
  • 89.    Dholi SK, Raparla R, Kannappan S. Synergic activity of ...
  • 90.    Patil P, Patil S, Mane A, Verma S. Antidiabetic ...
  • 91.    Sunarwidhi AL, Sudarsono S, Nugroho AE. Hypoglycemic effect of ...
  • 92.    Shailey S, Basir SF. Protective role of Azadirachta indica ...
  • 93.    Shailey S, Basir SF. Strengthening of anti-oxidant defense by ...
  • 94.    Karole S, Shrivastava S, Thomas S, Soni B, Khan ...
  • 95.    TK MM, TE FH, Musambil M, Mirshad P, OM ...
  • 96.    Akhtar N, Khan BA, Majid A, Khan S, Mahmood ...
  • 97.    Khosla P, Bhanwra S, Singh J, Seth S, Srivastava ...
  • 98.    Upreti J, Ali S, Basir SF. Effect of lower ...
  • 99.    Gupta NK, Srivastva N, Puri S, Bubber P, Puri ...
  • 100.    Atangwho IJ, Ebong PE, Egbung GE, Ani IF. Effects ...
  • 101.    Akinola OB, Caxton-Martins EA, Dini L. Chronic treatment with ...
  • 102.    Dallaqua B, Saito FH, Rodrigues T, Calderon IMP, Rudge ...
  • 103.    Atangwho IJ, Ebong PE, Eyong EU, Asmawi MZ, Ahmad ...
  • 104.    Perez Gutierrez RM, de Jesus Martinez Ortiz M. Beneficial ...
  • 105.    Gupta NK, Srivastva N, Bubber P, Puri S. The ...
  • 106.    Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific ablation of ...
  • 107.    Kumar R, Arora V, Ram V, Bhandari A, Vyas ...
  • 108.    Patel SS, Shah RS, Goyal RK. Antihyperglycemic, antihyperlipidemic and ...
  • 109.    Yadav D, Chaudhary AA, Garg V, Anwar MF, Rahman ...
  • 110.    Bhat M, Kothiwale SK, Tirmale AR, Bhargava SY, Joshi ...
  • 111.    Kosta S, Tiwari A. Screening and assessment of anti-diabetic ...
  • 112.    Jani DK, Goswami S. Screening of the herbal extracts ...
  • 113.    Chattopadhyay R. Possible mechanism of antihyperglycemic effect of Azadirachta ...
  • 114.    Muhtadi A, Irenka Y, Ayu WC, Hendriani R, Zuhrotun ...
  • 115.    Omobowale TO, Oyagbemi A, Ugbor F, Adejumobi O, Adedapo ...
  • 116.    Adejumobi O, Omobowale T, Oyagbemi A, Ayenuro O, Ola-Davies ...
  • 117.    Koley K, Lal J. Pharmacological effects of Azadirachta indica ...
  • 118.    Thompson EB, Anderson CC. Cardiovascular effects of Azadirachta indica ...
  • 119.    Kataria M, Gupta P, Gupta S. Hypolipidaemic and anti-atherogenic ...
  • 120.    Saleem T, Mumtaz U, Bashir MU, Qureshi HJ, Saleem ...
  • 121.    Nugroho AE, Sari KRP, Sunarwidhi AL. Blood glucose reduction ...
  • 122.    Kar A, Choudhary B, Bandyopadhyay N. Comparative evaluation of ...
  • 123.    Maithani A, Parcha V, Pant G, Kumar D, Dhulia ...
  • 124.    Tiwari BK, Pandey KB, Jaiswal N, Abidi A, Rizvi ...
  • 125.    Ebong PE, Atangwho IJ, Eyong EU, Egbung GE. The ...
  • 126.    Nagashayana G, Jagadeesh K, Shreenivas PR. Evaluation of hypoglycemic ...
  • 127.    Chandra A, Mahdi AA, Ahmad S, Singh RK. Indian ...
  • 128.    Chattopadhyay R. A comparative evaluation of some blood sugar ...
  • 129.    Akinola OB, Dosumu OO, Akinola OS, Zatta L, Dini ...
  • 130.    Akinola OB, Zatta L, Dosumu OO, Akinola OS, Adelaja ...
  • 131.    Gupta S, Kataria M, Gupta P, Murganandan S, Yashroy ...
  • 132.    Mishra A, Srivsatava R, Srivastava AK. Comparative antidiabetic profile ...
  • 133.    Ansarullah BB, Patel V, Ramachandran A. Improved glucoregulation, insulin ...
  • 134.    Neeraja Kamakshi U, Srinivasa Rao D, Yamini Suvarchala K, ...
  • 135.    Bakr A. Changes of hemoglobin content and glucose levels ...
  • 136.    Sanni O, Erukainure OL, Chukwuma CI, Koorbanally NA, Ibeji ...
  • 137.    Kaur L, Han K-S, Bains K, Singh H. Indian ...
  • نمایش کامل مراجع